OXIDIEN PHARMACEUTICALS ANNOUNCE ADDITION TO SCIENTIFIC AND MEDICAL ADVISORY BOARD
GAINESVILLE, FL, USA, July 9, 2020 /EINPresswire.com/ -- Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an underserved kidney disease indication, today announced three …